Stichting European Clinical Research Alliance on Infectious Diseases
- Address
- lock Available on a paid plan
Virus Diseases
At Stichting European Clinical Research Alliance on Infectious Diseases in Utrecht, the clinical research focus is centered on virus diseases, with studies addressing major respiratory infections in adults. The trials are designed to evaluate how well preventive vaccines work and how safely they can be used in older populations.
- Influenza virus prevention in adults aged 65 and older
- Respiratory Syncytial Virus and its impact in adults 50 years and above
- Assessment of vaccine effectiveness, immune response, and safety
The research includes efforts to compare influenza vaccines for protection against confirmed disease and to study whether an RSV vaccine can be used effectively alongside a COVID-19 mRNA vaccine, helping inform better vaccination strategies for respiratory infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Stichting European Clinical Research Alliance on Infectious Diseases
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of MF59-Adjuvanted Influenza Vaccine Versus Non-Adjuvanted Vaccine in Adults Aged 65 and Older | Seqirus UK Limited | Phase III | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227) | 1 | Unknown | 2023-10-20 | 2023-10-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.